CSIMarket
 


Genetic Technologies Limited  (GENE)
Other Ticker:  
 
 

GENE's Net Cash Flow Growth by Quarter and Year

Genetic Technologies Limited's Net Cash Flow results by quarter and year




GENE Net Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December 5.49 10.99 0.00 0.00
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   5.49 10.99 0.00 0.00



GENE Net Cash Flow forth quarter 2022 Y/Y Growth Comment
Genetic Technologies Limited reported drop in Net Cash Flow in the forth quarter 2022 by -50.07% to $ 5.49 millions, from the same quarter in 2021.
The fall in the forth quarter 2022 Genetic Technologies Limited's Net Cash Flow compares unfavorably to the Company's average Net Cash Flow drop of -50.06%.

According to the results reported in the forth quarter 2022, Genetic Technologies Limited achieved the best Net Cash Flow growth in Biotechnology & Pharmaceuticals industry. While Genetic Technologies Limited' s Net Cash Flow meltdown of -50.07% ranks overall at the positon no. 0 in the forth quarter 2022.




GENE Net Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December -50.07 % - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   -50.07 % - - -

Financial Statements
Genetic Technologies Limited's forth quarter 2022 Net Cash Flow $ 5.49 millions GENE's Income Statement
Genetic Technologies Limited's forth quarter 2021 Net Cash Flow $ 10.99 millions Quarterly GENE's Income Statement
New: More GENE's historic Net Cash Flow Growth >>


GENE Net Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   -50.07 % - - -




Net Cash Flow forth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0

Net Cash Flow Y/Y Growth Statistics
High Average Low
-50.06 % -50.06 % -50.06 %
(Jun 30 2019)  
Net Cash Flow forth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Y/Y Growth Statistics
High Average Low
-50.06 % -50.06 % -50.06 %
(Jun 30 2019)  

Net Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Genetic Technologies Limited's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
-100 % -100 % -100 %
0  


GENE's IV. Quarter Q/Q Net Cash Flow Comment


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Q/Q Growth Statistics
High Average Low
-100 % -100 % -100 %
0  


GENE's IV. Quarter Q/Q Net Cash Flow Comment


Genetic Technologies Limited's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Net Cash Flow 12 Months Ending $ 5.49 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Cash Flow Growth (TTM) -50.06 % - - - -
Year on Year Net Cash Flow Growth Overall Ranking # 337 # 0 # 0 # 0 # 0
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking